The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Cambrex Corp

NYSE: CBM
Last

(U.S.) $54.05

Today's change0.00 0.00%
Updated January 17 4:02 PM EST. Delayed by at least 15 minutes.
 

Cambrex Corp

NYSE: CBM
Last

(U.S.) $54.05

Today's change0.00 0.00%
Updated January 17 4:02 PM EST. Delayed by at least 15 minutes.

Cambrex Corp closed at (U.S.)$54.05.

Shares have lost 3.48% for the last five days, but have gained 29.28% over the last 52 weeks. This security has outperformed the S&P 500 by 8.66% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $54.05
  • High--
  • Low--
  • Bid / Ask(U.S.) $53.70 / (U.S.) $0.00
  • YTD % change+0.19%
  • Volume0
  • Average volume (10-day)239,351
  • Average volume (1-month)273,877
  • Average volume (3-month)315,596
  • 52-week range(U.S.) $29.50 to (U.S.) $59.41
  • Beta1.94
  • Trailing P/E26.60×
  • P/E 1 year forward20.06×
  • Forward PEG1.34×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.03
Updated January 17 4:02 PM EST. Delayed by at least 15 minutes.
S&P TSX0.00%Sector:HealthcareIndustry:Pharmaceuticals - Diversified

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue9911995156
Total other revenue--------
Total revenue9911995156
Gross profit38493966
Total cost of revenue62705690
Total operating expense808873125
Selling / general / administrative15141416
Research & development3434
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)------16
Other operating expenses, total--------
Operating income19312131
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax19312131
Income after tax14211517
Income tax, total510714
Net income9201518
Total adjustments to net income--------
Net income before extra. items14211517
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items14211517
Inc. avail. to common incl. extra. items9201518
Diluted net income9201518
Dilution adjustment--------
Diluted weighted average shares33333333
Diluted EPS excluding extraordinary itemsvalue per share0.420.630.450.53
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.420.630.450.79